로딩 중…
지수 로딩 중…
GC Corp.
005250· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩10,700-4.89%
2026-06-19
Price Chart
GC Corp.-34.56%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 503.20B KRW |
| Revenue | 2.49T KRW |
| Net Income | -69.51B KRW |
| Total Assets | 4.07T KRW |
| Net Assets | 1.76T KRW |
| Employees | 155 |
| Value | |
| P/B | 0.29x |
| P/S | 0.20x |
| EV/EBITDA | 49.39x |
| FCF Yield | -17.20% |
| Profitability | |
| ROE | -3.94% |
| ROA | -1.71% |
| Op. Margin | 1.45% |
| Revenue Growth | 8.13% |
| Earnings Growth | -184.24% |
| Financial Health | |
| Debt Ratio | 130.71% |
| Total Debt | 1.37T KRW |
| FCF | -86.57B KRW |
| Cash | 81.50B KRW |
| Current Ratio | 0.94x |
| Net Debt/EBITDA | 35.50x |
| Dividend | |
| Div. Yield | 2.67% |
| Div. Growth | -40.00% |
| Performance | |
| 1Y Return | -34.56% |
| 1M Return | -34.64% |
| From 52W High | -40.59% |
| 1Y MDD | -43.72% |
| Trading | |
| Volume | 166,887 shares |
| Foreign Own. | 8.49% |
| Per Share | |
| EPS | -1,812 KRW |
| BPS | 19,023 KRW |
Company Info
Established in 1967 and headquartered in Yongin, Gyeonggi, Green Cross Holdings transitioned into a holding company in 2001. It oversees a total of 56 domestic and international corporate affiliates, led by Green Cross, primarily in biotechnology and healthcare. The company performs holding company roles such as management strategy and investment asset portfolio management, while actual business operations are handled by its subsidiaries. In 2025, it expanded its business scope by acquiring ABO Holdings to enter the US blood center business and consolidating 15 new companies including Bibros.